首页|环状RNA_0056992通过靶向微小RNA-136-5p/叉头框蛋白2信号轴促进肺腺癌增殖、侵袭、转移

环状RNA_0056992通过靶向微小RNA-136-5p/叉头框蛋白2信号轴促进肺腺癌增殖、侵袭、转移

扫码查看
目的 探讨环状RNA(circRNA)_0056992通过调控微小RNA(miR)-136-5p/叉头框蛋白2(FOXN2)信号轴在肺腺癌(LUAD)发生发展过程中的作用。方法 收集2021年至2022年于唐山市人民医院治疗的LUAD患者(21例)的血浆及健康人(21例)血浆,通过实时定量聚合酶链反应(qRT-PCR)实验检测LUAD血浆及细胞中circ_0056992的表达情况。核糖核酸酶R(RNase R)和放线菌素D实验验证circ_0056992的环状结构。荧光原位杂交实验及核质分离实验验证circ_0056992、miR-136-5p 及 FOXN2 的细胞定位。将 LUAD 细胞分为 sh-NC 组与 shR-circ_0056992组,pSilencer-NC+ASO-NC 组、pSilencer-NC+ASO-136-5p 组、shR_circ_0056992+ASO-NC 组与shR_circ_0056992+ASO-136-5p组。采用细胞计数试剂盒(CCK-8)、克隆形成、5-乙炔基-2'-脱氧尿嘧啶核苷(EdU)、Transwell和划痕实验检测细胞增殖、侵袭和迁移。miRanda网站预测circ_0056992与miR-136-5p,miR-136-5p与FOXN2的结合位点。双荧光素酶实验验证circ_0056992与miR-136-5p以及miR-136-5p与FOXN2之间的靶向关系。多组比较采用单因素方差分析,两组间比较采用独立样本t 检验。结果 circ_0056992 在 LUAD 血浆(1。048±0。108 比 0。363±0。266,t=10。950,P<0。05)及细胞(0。193±0。019 比 1。001±0。063,F=21。220,P<0。05)中低表达。circ_0056992 为环状结构且circ_0056992和miR-136-5p共定位在细胞质,FOXN2在细胞质中较多。CCK-8、克隆和EdU 结果显示,shR-circ_0056992 组细胞增殖能力高于 NC 组(1。708±0。102 比 1。000±0。014;1。600±0。177 比 1。000±0。046;1。476±0。050 比 1。000±0。051,t=11。910、5。679、11。590,均 P<0。05)。划痕结果显示,24 h及48 h后shR-circ_0056992组细胞迁移能力高于NC组(0。485±0。009比 0。636±0。046;0。254±0。024 比 0。442±0。016,t=6。933、5。553,均P<0。05)。Transwell 结果显示,shR-circ_0056992 组细胞侵袭能力高于 NC组(907。700±67。020 比 565。700±67。010,t=11。160,P<0。05)。miRanda 网站预测显示,circ_0056992 与 miR-136-5p 存在结合位点。CCK-8、克隆形成及EdU结果显示,shR_circ_0056992+ASO-NC组细胞增殖能力均高于pSilencer-NC+ASO-NC 组及 shR_circ_0056992+ASO-136-5p 组(1。267±0。017 比 0。761±0。004、0。719±0。006;1。466±0。212 比 1。000±0。039、0。800±0。057;1。497±0。042 比 1。000±0。073、0。833±0。053,F=2 605。000、21。050、108。100,均 P<0。05),pSilencer-NC+ASO-136-5p 组均低于 pSilencer-NC+ASO-NC 组及 shR_circ_0056992+ASO-136-5p 组(0。458±0。004 比 0。761±0。004、0。719±0。006;0。170±0。023 比 1。000±0。039、0。800±0。057;0。418±0。064 比 1。000±0。073、0。833±0。053,F=4 123。000、319。900、65。820,均 P<0。05)。Transwell 结果显示,shR_circ_0056992+ASO-NC 组细胞侵袭能力高于 pSilencer-NC+ASO-NC 组及 shR_circ_0056992+ASO-136-5p 组(1。574±0。090 比1。000±0。030、0。841±0。046,F=119。800,均 P<0。05),pSilencer-NC+ASO-136-5p 组均低于pSilencer-NC+ASO-NC 组及 shR_circ_0056992+ASO-136-5p 组(0。598±0。134 比 1。000±0。030、0。841±0。046,F=17。630,P<0。05)。划痕结果显示,24 h 和 48 h 后,shR_circ_0056992+ASO-NC组细胞的迁移剩余距离均低于pSilencer-NC+ASO-NC组及shR_circ_0056992+ASO-136-5p组(0。540±0。017 比 0。707±0。012、0。735±0。026;0。360±0。036 比 0。509±0。053、0。564±0。042,F=92。710、17。150,均 P<0。05)。pSilencer-NC+ASO-136-5p 组均高于 pSilencer-NC+ASO-NC 组及shR_circ_0056992+ASO-136-5p 组(0。886±0。040 比 0。707±0。012、0。735±0。026;0。714±0。030 比0。509±0。053、0。564±0。042,F=35。280、18。640,P<0。05)。miRanda 网站预测显示 miR-136-5p 与FOXN2存在结合位点。结论 circ_0056992可通过调控miR-136-5p/FOXN2信号轴促进肺腺癌增殖、侵袭、转移。
Circle_0056992 promotes the proliferation,invasion and metastasis of lung adenocarcinoma by targeting microRNA-136-5p/forkhead box protein N2 signal axis
Objective To investigate the role of circular RNA(circRNA)_0056992 in the devel-opment of lung adenocarcinoma by regulating the microRNA(miR)-136-5p/forkhead box protein 2 signa-ling axis.Methods Plasma from LUAD patients(21 cases)treated in Tangshan People's Hospital from 2021 to 2022 and plasma from healthy individuals(21 cases)were collected,and the expression of circ_0056992 was detected in LUAD plasma and cells by real-time quantitative polymerase chain reaction assay.Ribonuclease R and actinomycin D assays were performed to verify the cyclic structure of circ_0056992.Fluorescence in situ hybridization assay and nucleoplasmic separation assay were performed to verify the cellular localization of circ_0056992,miR-136-5p and FOXN2.LUAD cells were divided into sh-NC group and shR-circ_0056992 group,pSilencer-NC+ASO-NC group,pSilencer-NC+ASO-136-5p group,shR_circ_0056992+ASO-NC group and shR_circ_0056992+ASO-136-5p group.Cell proliferation,inva-sion and migration were detected using cell counting reagent,clone formation,5-ethynyl-2'-deoxyuridine nucleoside,Transwel and scratch assays.miRanda website predicted the binding sites of circ_0056992 with miR-136-5p and miR-136-5p with FOXN2.Dual luciferase assays were performed to validate the targeting relationship between circ_0056992 and miR-136-5p and between miR-136-5p and FOXN2.One-way ANOVA was used for multiple group comparisons,and independent samples t-test was used for comparisons between two groups.Results Circ_0056992 was lowly expressed in LUAD plasma(1.048±0.108 vs.0.363±0.266,t=10.950,P<0.05)and cells(0.193±0.019 vs.1.001±0.063,F=21.220,P<0.05).circ_0056992 was cyclic,and circ_0056992 and miR-136-5p co-localized in the cytoplasm,and FOXN2 was more abundant in the cytoplasm.Cell counting kit-8(CCK-8),clonogenic and EdU results showed that the cell proliferative capacity of the shR-circ_0056992 group was higher than that of the NC group(1.708±0.102 vs.1.000±0.014;1.600±0.177 vs.1.000±0.046;1.476±0.050 vs.1.000±0.051,t=11.910,5.679,11.590,all P<0.05).Scratch results showed that the cell migration ability of shR-circ_0056992 group was higher than that of NC group after 24 h and 48 h(0.485±0.009 vs.0.636±0.046;0.254±0.024 vs.0.442±0.016,t=6.933,5.553,all P<0.05).Transwell results showed that the cell invasion ability of shR-circ_0056992 group was higher than that of NC group(907.700±67.020 vs.565.700±67.010,t=11.160,P<0.05).miRanda website prediction showed that there was a binding site between circ_0056992 and miR-136-5p.CCK-8,clone formation and EdU results showed that the cell proliferation ability of shR_circ_0056992+ASO-NC group was higher than that of pSilencer-NC+ASO-NC group and shR_circ_0056992+ASO-136-5p group(1.267±0.017 vs.0.761±0.004,0.719±0.006;1.466±0.212 vs.1.000±0.039,0.800±0.057;1.497±0.042 vs.1.000±0.073,0.833±0.053,F=2 605.000,21.050,108.100,all P<0.05),and that in the pSilencer-NC+ASO-136-5p group was lower than in the pSilencer-NC+ASO-NC group and the shR_circ_0056992+ASO-136-5p group(0.458±0.004 vs.0.761±0.004,0.719±0.006;0.170±0.023 vs.1.000±0.039,0.800±0.057;0.418±0.064 vs.1.000±0.073,0.833±0.053,F=4 123.000,319.900,65.820,all P<0.05).Transwell results showed that the cell invasion ability of shR_circ_0056992+ASO-NC group was higher than pSilencer-NC+ASO-NC group and shR_circ_0056992+ASO-136-5p group(1.574±0.090 vs.1.000±0.030,0.841±0.046,F=119.800,all P<0.05),and that in the pSilencer-NC+ASO-136-5p group was lower than pSilencer-NC+ASO-NC group and shR_circ_0056992+ASO-136-5p group(0.598±0.134 vs.1.000±0.030,0.841±0.046,F=17.630,P<0.05).The scratch results showed that the migration residual distance of cells in the shR_circ_0056992+ASO-NC group was shorter than that in the pSilencer-NC+ASO-NC group and the shR_circ_0056992+ASO-136-5p group after 24 h and 48 h(0.540±0.017 vs.0.707±0.012,0.735±0.026;0.360±0.036 vs.0.509±0.053,0.564±0.042,F=92.710,17.150,all P<0.05).The migration residual distance of cells in pSilencer-NC+ASO-136-5p group was longer than pSilencer-NC+ASO-NC group and shR_circ_0056992+ASO-136-5p group(0.886±0.040 vs.0.707±0.012,0.735±0.026;0.714±0.030 vs.0.509±0.053,0.564±0.042,F=35.280,18.640,P<0.05).miRanda website prediction showed that miR-136-5p had a binding site with FOXN2.Conclusion Circ_0056992 can promote lung adenocar-cinoma proliferation,invasion,and metastasis by regulating the miR-136-5p/FOXN2 signaling axis.

Circular RNAMicroRNAForkhead box protein 2Lung adenocarcinoma

张梦诗、崔逸爽、刘维、冯业、么艺涵、洪紫谦、孙国贵

展开 >

华北理工大学公共卫生学院,唐山 063210

华北理工大学附属医院放化疗科,唐山 063000

环状RNA 微小RNA 叉头框蛋白2 肺腺癌

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(9)